9-valent 2-dose HPV vaccination
Showing 1 - 25 of >10,000
HPV Infection Trial in Boston (Gardasil 9 2 dose regimen, Gardasil 9 3 dose regimen, Gardasil 9 rescue dose)
Recruiting
- HPV Infection
- Gardasil 9 2 dose regimen
- +2 more
-
Boston, MassachusettsBoston Medical Center
Dec 16, 2022
Human Papillomavirus Vaccine Trial in Banjul (9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses, 9-valent human
Active, not recruiting
- Human Papillomavirus Vaccine
- 9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses
- +2 more
-
Banjul, Outside U.S. And Canada, GambiaEd Clarke
Mar 15, 2022
Immunization, Efficacy, Human Papilloma Virus Trial in Galveston (9-valent HPV vaccine, 2 dose efficacy, 9-valent HPV vaccine, 3
Recruiting
- Immunization
- +2 more
- 9-valent HPV vaccine, 2 dose efficacy
- 9-valent HPV vaccine, 3 doses standard timing
-
Galveston, TexasUniversity of Texas Medical Branch
Jan 30, 2023
HPV - Anogenital Human Papilloma Virus Infection, HIV Trial in Brussels (Vaccine)
Active, not recruiting
- HPV - Anogenital Human Papilloma Virus Infection
- HIV Infections
- Vaccine
-
Brussels, BelgiumService de Maladies Infectieuses, CHU Saint-Pierre
Jul 19, 2022
Immunization, HPV Infection, Human Papillomavirus Trial in Galveston (9-valent HPV vaccine, 2 doses alternate timing, 9-valent
Recruiting
- Immunization
- +2 more
- 9-valent HPV vaccine, 2 doses alternate timing
- 9-valent HPV vaccine, 3 doses standard timing
-
Galveston, TexasUniversity of Texas Medical Branch
Jan 30, 2023
Warts Trial in Salt Lake City (Human Papillomavirus 9-valent Vaccine, Recombinant, Normal Saline)
Not yet recruiting
- Warts
- Human Papillomavirus 9-valent Vaccine, Recombinant
- Normal Saline
-
Salt Lake City, Utah
- +1 more
Nov 23, 2022
Human Papillomavirus-Related Carcinoma Trial in Austria, United States (procedure, biological, other)
Not yet recruiting
- Human Papillomavirus-Related Carcinoma
- Biospecimen Collection
- +4 more
-
Birmingham, Alabama
- +4 more
Aug 9, 2023
HPV Trial in Atlanta (Gardasil, Lidocaine injections)
Recruiting
- HPV
- Gardasil
- Lidocaine injections
-
Atlanta, Georgia
- +1 more
Dec 21, 2021
Anal Intraepithelial Neoplasia, Anal Cancer, Human Papilloma Virus Trial in Vancouver, Ottawa, Toronto (9-valent HPV
Not yet recruiting
- Anal Intraepithelial Neoplasia
- +2 more
- 9-valent HPV vaccination
-
Vancouver, British Columbia, Canada
- +3 more
Jun 9, 2022
Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Yangchun (4-valent HPV Vaccine, 9-valent HPV Vaccine, GARDASIL®)
Completed
- Cervical Cancer
- +13 more
- 4-valent HPV Vaccine
- +2 more
-
Yangchun, Guangdong, ChinaYangchun Center For Disease Prevention And Control
Feb 23, 2022
HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Guangxi (Experimental: Experimental: 9-valent Human Papillomavirus
Completed
- HPV Infections
- +14 more
- Experimental: Experimental: 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
- Active Comparator: GARDASIL ®9
-
Guangxi, ChinaGuangxi Zhuang Autonomous Region Center for Disease Control and
May 9, 2022
HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Hangzhou (9-valent HPV vaccine)
Recruiting
- HPV Infections
- +14 more
- 9-valent HPV vaccine
-
Hangzhou, ChinaHuakun Lv
Feb 23, 2022
Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Tumor Trial in Houston (Recombinant
Active, not recruiting
- Allogeneic Hematopoietic Stem Cell Transplant Recipient
- Hematopoietic and Lymphoid Cell Neoplasm
- Recombinant Human Papillomavirus Nonavalent Vaccine
-
Houston, TexasM D Anderson Cancer Center
Jun 29, 2022
Cervical Intraepithelial Neoplasia, Cervical Dysplasia Trial in New Haven (9-valent HPV vaccine, Imiquimod)
Active, not recruiting
- Cervical Intraepithelial Neoplasia
- Cervical Dysplasia
- 9-valent HPV vaccine
- Imiquimod
-
New Haven, ConnecticutSmilow Cancer Hospital at Yale New Haven
Aug 5, 2022
Genital Warts Trial in Guang'an, Mianyang (9vHPV vaccine)
Recruiting
- Genital Warts
- 9vHPV vaccine
-
Guang'an, Sichuan, China
- +1 more
May 11, 2022
HPV Infection, Hiv, HPV Vaccine Trial in Swaziland (Gardasil ® 9)
Recruiting
- HPV Infection
- +2 more
- Gardasil ® 9
-
Bulembu, Swaziland
- +7 more
May 16, 2022
Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III), Human Papillomavirus (HPV) Infections, High-risk HPV Trial
Recruiting
- Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)
- +3 more
- Nonavalent HPV vaccine (9vHPV/Gardasil-9™).
-
L'Hospitalet De Llobregat, Catalunya, SpainGynaecology Unit, Bellvitge University Hospital (HUB)
Jan 24, 2023
Cervical Carcinoma, Human Papillomavirus Infection Trial in Liberia (Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis
Enrolling by invitation
- Cervical Carcinoma
- Human Papillomavirus Infection
- Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
- +3 more
-
Liberia, Guanacaste, Costa RicaAgencia Costarricense de Investigaciones Biomédicas - Fundación
Aug 11, 2022
Human Papillomavirus Infection Trial in Montreal (HPV vaccine, Gardasil 9, Hepatitis A vaccine)
Active, not recruiting
- Human Papillomavirus Infection
- HPV vaccine, Gardasil 9
- Hepatitis A vaccine
-
Montreal, Quebec, CanadaMcGill University - Division of Cancer Epidemiology
Oct 20, 2022
Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Rongan County (9-valent Human Papillomavirus (Types 6, 11, 16,
Recruiting
- Cervical Cancer
- +13 more
- 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha)
- GARDASIL®
-
Rongan County, Guangxi Zhuang Autonomous Region, ChinaRongan County Center for Disease Control and Prevention
Feb 20, 2022
Papilloma Viral Infection Trial in Saint-Pierre (Gardasil 9, 9-Valent Intramuscular Suspension)
Completed
- Papilloma Viral Infection
- Gardasil 9, 9-Valent Intramuscular Suspension
-
Saint-Pierre, FranceCentre Hospitalier Universitaire de la Réunion
Mar 1, 2022
HPV Vaccine in Postpartum Women
Withdrawn
- HPV Infection
- HPV 9-valent Vaccine, Recombinant
- (no location specified)
Jun 30, 2021
Human Papillomavirus Trial in Vancouver (Human Papillomavirus 9-valent Vaccine, Recombinant)
Completed
- Human Papillomavirus
- Human Papillomavirus 9-valent Vaccine, Recombinant
-
Vancouver, British Columbia, CanadaVaccine Evaluation Center, BC Children's Hospital Research Insti
Jun 23, 2021
HPV Infection, Vaccine Preventable Disease Trial in Mwanza (Gardasil® HPV vaccine)
Not yet recruiting
- HPV Infection
- Vaccine Preventable Disease
- Gardasil® HPV vaccine
- (no location specified)
Jun 28, 2021